ImmunologybioRxivPreprint
CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetes
Shiva Pathak, Rizwan Ahmed, Nadine Nagy…·Everett H. Meyer
The paper identifies CD38 as a marker for pathogenic T cells in T1D and shows that anti-CD38 mAb selectively depletes these cells to prevent diabetes without affecting Tregs.